<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=799546403794687&amp;ev=PageView&amp;noscript=1">

School of Medicine News and Stories


Research    Innovation   

Clinical Trial for Gene Therapy Treatment Cures Sickle Cell Disease Patient at CU

The University of Colorado School of Medicine’s Sickle Cell Treatment and Research Center entered its 50th year with a major research victory: An experimental gene therapy has been successful in curing a patient of sickle cell disease (SCD), which affects millions of people around the globe.

Author Kara Mason | Publish Date May 11, 2023
Full Story

Research    Innovation   

Center for Surgical Innovation Celebrates One Year in New Location, Looks Forward to the Future

When Sarah Massena joined the Center for Surgical Innovation (CSI) as executive director in 2007, she saw the role as an ideal way to merge her interests in science and business.

Author Valerie Gleaton | Publish Date May 04, 2021
Full Story

Innovation    Patient Care    Community   

What to Know About the COVID-19 Vaccine

With the FDA emergency approval of the COVID-19 vaccine from Pfizer last week and Moderna approval due any day, immunizations against the deadliest pandemic in the past 100 years will begin this week.

Author School of Medicine | Publish Date December 14, 2020
Full Story

School of Medicine In the News

American Journal of Managed Care

Dr Jeffrey Sippel: The Impact of Insurance Denials for Patients With ALS

news outletAmerican Journal of Managed Care
Publish DateNovember 16, 2023

Due to the frequent rejection of claims for noninvasive ventilators (NIVs) by Medicare Advantage plans, individuals with amyotrophic lateral sclerosis (ALS) are experiencing disproportionately high rates of hospital admissions for inpatient care.

More News
Multiple Sclerosis News Today

Blood test for antibody clumps may support MS diagnosis

news outletMultiple Sclerosis News Today
Publish DateNovember 16, 2023

Measuring the amount of specific antibody clumps in the blood helped distinguish people with multiple sclerosis (MS) from healthy individuals and people with other conditions with an accuracy of at least 90%, a new study has found.

More News

Efficacy of Nonhormonal Treatment for Patients With VMS Considered Unsuitable, Unwilling to Take Hormone Therapy

news outletConsultant360
Publish DateNovember 16, 2023

In this video, Nanette Santoro, MD, discusses the efficacy of nonhormonal treatment for patients with vasomotor symptoms (VMS), also called hot flashes or night sweats, in subgroups of patients considered unsuitable for or unwilling to take hormone therapy based on hormonal therapy history, the efficacy of the nonhormonal treatment for patients with VMS in menopause according to time of day, and pooled safety data over 52 weeks of the nonhormonal treatment for patients with VMS in menopause.

More News
U.S. News & World Report

How Hospitals and Health Systems Are Battling Burnout in Health Care

news outletU.S. News & World Report
Publish DateNovember 16, 2023

Some 46% of health care workers reported experiencing burnout in 2022, according to a recent report released by the Centers of Disease Control and Prevention, up from 32% in 2018. Some estimates have even placed the cost of burnout to the U.S. health system at $4.6 billion annually.

More News